Our results suggest that interventions to improve liver and kidney function, raise growth hormone and testosterone levels, reduce systemic inflammation, improve glycemic control and treat anemia may represent viable strategies for preventing certain cases of new-onset MDD. The gene discussed is GH1; the disease is major depressive disorder.